Author

Hongwei Liu

h-index 3 View on Semantic Scholar

We have 3 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

A cytoplasmic cis-acting circuit confines PI3K/AKT-driven lineage plasticity in bladder cancer.

Bladder cancer (BCa) is a prevalent urological malignancy characterized by high recurrence rates and limited therapeutic options for advanced disease. Circular RNAs (circRNAs) have emerged as critical regulators of gene expression in cancer, yet their roles in BCa progression remain incompletely understood. Here, circ_...

Xuan Dong, Yu-Tong Li, Yong-Tai Yan et al. · Cellular Signalling · 0 citations

Open access Oct 2026

NU-1025 Modulates Immunogenic Cell Death in Bladder Cancer: A Multi-omics Insight.

Immune checkpoint blockade has shown limited efficacy in bladder cancer, underscoring the need for therapeutic strategies that enhance tumor immunogenicity. Immunogenic cell death (ICD) can stimulate adaptive immunity and remodel the tumor microenvironment, yet its comprehensive landscape and druggable potential in bla...

Yu-Tong Li, Ling Zuo, Xuan Dong et al. · SLAS technology · 0 citations

Jul 2026

EIF4A3 facilitates METTL3-mediated m6A methylation of circPCMTD1 to drive bladder cancer progression via miR-3681-5p/HPSE axis.

A novel EIF4A3/m6A-circPCMTD1/miR-3681-5p/HPSE/PI3K/AKT axis is identified and suggests potential therapeutic targets for BCa.

Lingbao Xiang, Yu-Tong Li, Xuan Dong et al. · Cellular Signalling · 0 citations